• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD40 介导的慢性淋巴细胞白血病细胞的激活促进了它们对透明质酸的 CD44 依赖性黏附,并限制了 CCL21 诱导的迁移。

CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.

机构信息

Laboratory for Immunological and Molecular Cancer Research, Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Paracelsus Medical University, Salzburg, Austria.

出版信息

Cancer Res. 2013 Jan 15;73(2):561-70. doi: 10.1158/0008-5472.CAN-12-2749. Epub 2012 Nov 1.

DOI:10.1158/0008-5472.CAN-12-2749
PMID:23117883
Abstract

Microenvironmental interactions are crucial for the survival and proliferation of chronic lymphocytic leukemia (CLL) cells. CD4+ T cells that express CD40 ligand (CD40L), along with other accessory immune and stromal cells within CLL lymph nodes, provide signals needed for activation and outgrowth of the tumor clone. Furthermore, correct positioning of CLL cells within lymphoid subcompartments is essential for the transmission of these supportive signals. Thereby, interstitial cell migration and adhesion events, influenced by activational stimuli, determine CLL cell localization. CD44 has been implicated in cell activation, migration, and tissue retention via binding to its extracellular matrix ligand hyaluronan (HA). In this study, we investigated the role of CD44-HA interactions for CLL positioning and interaction with supportive microenvironments in peripheral lymph nodes, focusing on its regulation via CD40L-dependent, T-cell-mediated activation of CLL cells. We found that hyaluronan triggered a robust CCL21-induced motility of resting CLL cells. However, CD40L stimulation promoted the firm, CD44-mediated adhesion of CLL cells to hyaluronan, antagonizing their motile behavior. N-linked glycosylations of CD44, particularly associated with the variant isoform CD44v6 after CD40L activation, seemed to facilitate hyaluronan recognition by CD44. We propose that the CD40L-CD40 signaling axis provides a stop signal to motile CLL cells within lymph node compartments by inducing high avidity CD44-HA adhesion. This might retain CLL cells close to T-cell stimuli and facilitate essential interactions with hyaluronan-bearing stromal cells, collectively promoting CLL cell proliferation and survival.

摘要

微环境相互作用对于慢性淋巴细胞白血病 (CLL) 细胞的存活和增殖至关重要。表达 CD40 配体 (CD40L) 的 CD4+T 细胞以及 CLL 淋巴结中的其他辅助免疫和基质细胞,为肿瘤克隆的激活和生长提供了所需的信号。此外,CLL 细胞在淋巴亚区室中的正确定位对于这些支持信号的传递至关重要。因此,受激活刺激影响的间质细胞迁移和黏附事件决定了 CLL 细胞的定位。CD44 通过与其细胞外基质配体透明质酸 (HA) 结合,参与细胞激活、迁移和组织保留。在这项研究中,我们研究了 CD44-HA 相互作用对于 CLL 定位和与外周淋巴结中支持性微环境相互作用的作用,重点关注其通过 CD40L 依赖性、T 细胞介导的 CLL 细胞激活的调节。我们发现透明质酸触发静止 CLL 细胞强烈的 CCL21 诱导迁移。然而,CD40L 刺激促进了 CLL 细胞与透明质酸的牢固、CD44 介导的黏附,拮抗了它们的迁移行为。CD44 的 N-连接糖基化,特别是在 CD40L 激活后与变体同工型 CD44v6 相关,似乎促进了 CD44 对透明质酸的识别。我们提出,CD40L-CD40 信号轴通过诱导高亲和力 CD44-HA 黏附,为淋巴结区室中迁移的 CLL 细胞提供停止信号。这可能使 CLL 细胞靠近 T 细胞刺激物,并促进与携带透明质酸的基质细胞的必要相互作用,共同促进 CLL 细胞的增殖和存活。

相似文献

1
CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.CD40 介导的慢性淋巴细胞白血病细胞的激活促进了它们对透明质酸的 CD44 依赖性黏附,并限制了 CCL21 诱导的迁移。
Cancer Res. 2013 Jan 15;73(2):561-70. doi: 10.1158/0008-5472.CAN-12-2749. Epub 2012 Nov 1.
2
IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells.自体 T 细胞的 IL-21 和 CD40L 信号可诱导 CLL 细胞的抗原非依赖性增殖。
Blood. 2013 Oct 24;122(17):3010-9. doi: 10.1182/blood-2012-11-467670. Epub 2013 Sep 6.
3
Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.治疗慢性淋巴细胞白血病需要采用新型治疗方法靶向保护性淋巴结环境。
Leuk Lymphoma. 2012 Apr;53(4):537-49. doi: 10.3109/10428194.2011.610014. Epub 2011 Sep 23.
4
CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis.CD40 信号通路通过 CCR2 轴指导慢性淋巴细胞白血病细胞吸引单核细胞。
Haematologica. 2017 Dec;102(12):2069-2076. doi: 10.3324/haematol.2016.157206. Epub 2017 Sep 29.
5
Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.微环境诱导的 CD44v6 促进慢性淋巴细胞白血病的早期疾病进展。
Blood. 2018 Mar 22;131(12):1337-1349. doi: 10.1182/blood-2017-08-802462. Epub 2018 Jan 19.
6
Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.来自淋巴结的小鼠成纤维网状细胞通过CD40-CD40L与CD4+T细胞相互作用。
Transplantation. 2015 Aug;99(8):1561-7. doi: 10.1097/TP.0000000000000710.
7
CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.用于肿瘤免疫治疗的CD40激活的B细胞慢性淋巴细胞白血病细胞:同种异体与自体T细胞刺激产生不同类型的效应细胞。
Blood. 1999 Mar 15;93(6):1992-2002.
8
Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.慢性淋巴细胞白血病B细胞具有通过产生CCL22吸引CD4⁺、CD40L⁺ T细胞的能力。
Eur J Immunol. 2002 May;32(5):1403-13. doi: 10.1002/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y.
9
CD40 activation: potential for specific immunotherapy in B-CLL.CD40激活:B细胞慢性淋巴细胞白血病特异性免疫治疗的潜力
Ann Oncol. 2004 Jun;15(6):853-7. doi: 10.1093/annonc/mdh213.
10
The role of hyaluronan and interleukin 8 in the migration of chronic lymphocytic leukemia cells within lymphoreticular tissues.透明质酸和白细胞介素8在慢性淋巴细胞白血病细胞在淋巴网状组织内迁移中的作用。
Cancer Res. 1999 Sep 1;59(17):4419-26.

引用本文的文献

1
The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia.微环境和细胞粘附分子在慢性淋巴细胞白血病中的作用
Cancers (Basel). 2023 Oct 26;15(21):5160. doi: 10.3390/cancers15215160.
2
Ibrutinib Does Not Impact CCR7-Mediated Homeostatic Migration in T-Cells from Chronic Lymphocytic Leukemia Patients.依鲁替尼不影响慢性淋巴细胞白血病患者T细胞中CCR7介导的稳态迁移。
Cancers (Basel). 2022 May 31;14(11):2729. doi: 10.3390/cancers14112729.
3
Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia.
阐明粘着斑激酶作为慢性淋巴细胞白血病迁移和侵袭的调节因子及潜在治疗靶点的作用。
Cancers (Basel). 2022 Mar 22;14(7):1600. doi: 10.3390/cancers14071600.
4
CCR7 in Blood Cancers - Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target.血液癌症中的CCR7——其病理生理作用及作为治疗靶点的潜力综述
Front Oncol. 2021 Oct 29;11:736758. doi: 10.3389/fonc.2021.736758. eCollection 2021.
5
Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody.伊布替尼对慢性淋巴细胞白血病中 CCR7 表达和功能的影响及其对新型治疗性抗 CCR7 抗体 CAP-100 活性的影响。
Cancer Immunol Immunother. 2022 Mar;71(3):627-636. doi: 10.1007/s00262-021-03014-2. Epub 2021 Jul 23.
6
Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL.用新型抗 CCR7 治疗性抗体靶向癌症归巢至淋巴结:CLL 的范例。
MAbs. 2021 Jan-Dec;13(1):1917484. doi: 10.1080/19420862.2021.1917484.
7
Extracellular matrix and its therapeutic potential for cancer treatment.细胞外基质及其在癌症治疗中的治疗潜力。
Signal Transduct Target Ther. 2021 Apr 23;6(1):153. doi: 10.1038/s41392-021-00544-0.
8
Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.关于淋巴结和 CLL 细胞:解析 CCR7 在 CLL 发病机制中的作用及其作为治疗靶点的潜力。
Front Immunol. 2021 Mar 24;12:662866. doi: 10.3389/fimmu.2021.662866. eCollection 2021.
9
Multifunctional, CD44v6-Targeted ORMOSIL Nanoparticles Enhance Drugs Toxicity in Cancer Cells.多功能的、靶向CD44v6的有机硅纳米颗粒增强癌细胞中的药物毒性。
Nanomaterials (Basel). 2020 Feb 10;10(2):298. doi: 10.3390/nano10020298.
10
Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia.蛋白质组学对慢性淋巴细胞白血病病理学和预后的见解
Saudi Med J. 2019 Apr;40(4):317-327. doi: 10.15537/smj.2019.4.23598.